CEL-SCI To Participate In Ascendiant’s Quarterly Management Discussion Series Today, Friday February 20 At 11 Am Eastern Time

CEL-SCI Corporation (NYSE MKT:CVM), a late stage cancer immunotherapy company, announced that Geert Kersten, Chief Executive Officer, will participate in Ascendiant’s Quarterly Management Discussion Series teleconference today, Friday, February 20, 2015, at 11 AM ET.

Interested parties may access the call by dialing +1-719-457-6209 and entering passcode 216781. A replay webcast link will be available on the investor relations section of www.cel-sci.com shortly after the call concludes.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC